Molecular Pathology in Drug Development

Molecular pathology deals with tools and techniques that can significantly improve the drug discovery and development methods which help to make the possibilities of personalized medicine a reality. Molecular Pathology in drug discovery and development offers an incomparable guide to this leading-edge discipline and its applications to pharmaceutical science. With assistances from foremost illuminations in drug discovery, drug development, and molecular pathology, this field compromises the methods that are applied to the progression of drug discovery and development. The effectual and operative improvement of new targeted drugs will involve more comprehensive molecular arrangements of histologically homogeneous diseases that show heterogeneous clinical outcomes, which can be gained using molecular techniques in drug development.

  • Molecular pathology in oncology target and drug discovery
  • Molecular pathology and transcriptional profiling in early drug development
  • Molecular pathology in nonclinical safety assessment
  • Molecular pathology in development of antibacterial drugs

Related Conference of Molecular Pathology in Drug Development

June 21-22, 2017

3rd International Conference on Cytopathology & Histopathology

Philadelphia, Pennsylvania, USA
June 26-27, 2017

8th World Congress on Molecular Pathology

San Diego,California,USA
August 02-03, 2017

13th European Pathology Congress

Milan, Italy
August 23-24, 2017

4th World Congress on Breast Pathology and Cancer Diagnosis

Toronto, Canada [Holiday Inn Toronto International Airport]
Sep 11-12, 2017

World Annual Pathologists Congress

Los Angeles, USA
November 13-14, 2017

14th Asia Pacific Pathology Congress

Osaka, Japan
November 15-16, 2017

2nd International Conference on Digital Pathology

San Antonio, USA

Molecular Pathology in Drug Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in